Abstract

A drug delivery system that is integrated with fluorescent imaging is an emerging platform for tumor diagnostic and therapy. A pH-responsive fluorescent polymer that can respond to the surrounding medium is a desired component with which to construct an advanced drug delivery system with bioimaging characteristics and controllable drug releasing. In this work, we synthesized novel amphiphilic block copolymers of poly(ethylene glycol)-b-poly(2-(diisopropylamino) ethyl methacrylate-co-dithiomaleimide) (PEG-b-poly(DPA-co-DTM)) and poly(ethylene glycol)-b-poly(2-(dibutylamino) ethyl methacrylate-co-dithiomaleimide) (PEG-b-poly(DBA-co-DTM)) with pH-responsiveness and fluorescence. The block copolymers exhibited relatively stable fluorescence properties in different solvent and excitation-independent fluorescence behaviours. By copolymerizing the responsive segments in the molecule chain, the doxorubicin (DOX)-loaded micelles could be triggered to disassemble, thus releasing DOX at the corresponding pH values and yielding a pH-responsive drug release. Targeted deliveries of the drug within the cell were demonstrated by using the carrier responding to different pH values. The best antitumor effect was obtained by PEG-b-poly(DPA-co-DTM), which immediately released DOX as soon as it entered the tumor cells, as a result of responding to the regional pH level (pH = 6.3). The pH-responsive copolymers showed excellent biocompatibilities, as nearly 85% of cells with these fluorescent micelles survive when the testing concentration goes up to 200 μg mL−1. In all, these pH-responsive and dithiomaleimide-based fluorescent block copolymers hold great potential in future cancer diagnostic and therapeutic techniques.

Highlights

  • Fluorescence imaging, a reliable strategy to detect and visualize bio-subjects both in vitro and in vivo [1,2,3], has led to wide applications in clinical practices [4,5,6,7]

  • From the perspective of scoping novel materials, the poly(2-(diisopropylamino) ethyl methacrylate) (PDPA) and poly(2-(dibutylamino) ethyl methacrylate) (PDBA) are found to be highly sensitive to pH in early endosomes and late endosomes/lysosomes, which explain their potentials in controlled drug delivery applications [24-29]

  • We propose a novel fluorescent and pH-responsive material strategy by co-polymerizing fluorescent DTM groups with pH-sensitive polymers (PDPA and PDBA), aiming to improve efficiency for cellular imaging and drug release

Read more

Summary

Introduction

Fluorescence imaging, a reliable strategy to detect and visualize bio-subjects both in vitro and in vivo [1,2,3], has led to wide applications in clinical practices [4,5,6,7]. Combining bioimaging with smart drug release to get multifunctional nanomaterials is of great significance in diagnostic and therapeutic applications [1617]. These imaging-guided drug delivery systems can visualize the accumulation of nanoparticles and simultaneously deliver and trace the drug, thereby evaluating the efficiency of drug delivery [17-18]. From the perspective of scoping novel materials, the poly(2-(diisopropylamino) ethyl methacrylate) (PDPA) and poly(2-(dibutylamino) ethyl methacrylate) (PDBA) are found to be highly sensitive to pH in early endosomes and late endosomes/lysosomes, which explain their potentials in controlled drug delivery applications [24-29]. We propose a novel fluorescent and pH-responsive material strategy by co-polymerizing fluorescent DTM groups with pH-sensitive polymers (PDPA and PDBA), aiming to improve efficiency for cellular imaging and drug release.

Experimental
Results and discussion
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.